This article provides a comprehensive overview of chemogenomic profiling as a powerful system-based approach for validating the mechanism of action (MoA) of small molecules in drug discovery.
This article provides a comprehensive framework for researchers and drug development professionals to benchmark chemogenomic libraries against diverse bioactive compound sets.
This article provides a comprehensive comparative analysis of network-based inference (NBI) methods for predicting drug-target interactions (DTIs) and drug repositioning.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of validating chemogenomic predictions using robust in vitro assays.
Accurate prediction of Drug-Target Interactions (DTIs) is a critical, yet challenging, step in accelerating drug discovery and repurposing.
This article provides a comprehensive framework for optimizing Absorption, Distribution, Metabolism, and Excretion (ADME) properties within chemogenomic libraries, which are essential tools for modern phenotypic and target-based drug discovery.
This article provides a comprehensive comparison of ligand-based and target-based chemogenomic approaches, two foundational strategies in contemporary drug discovery.
Chemogenomic screening has become a cornerstone of modern drug discovery, enabling the systematic exploration of chemical-genetic interactions on a genome-wide scale.
Membrane proteins represent a critical class of therapeutic targets, yet they present unique and formidable challenges for chemogenomic library design and screening.
This article provides a comprehensive guide for researchers and drug development professionals on the strategic selection of substituents for target-focused library scaffolds.